006280.KS
006280.KS
KR7006280002
GC Biopharma Corp.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.48T EUR
1.42T EUR
1.69T EUR
1.81T EUR
Enterprise Value
2.46T EUR
2.31T EUR
2.57T EUR
2.75T EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
--
--
--
--
Price to Sales
0.75x
0.72x
0.83x
1.13x
Price to Book
--
1.14x
1.38x
1.49x
EV/Revenue
1.25x
1.18x
1.26x
1.71x
EV/EBITDA
18.52x
13.63x
11.75x
18.51x
Price to FCF (P/FCF)
14.51x
25.14x
53.08x
19.23x
EV/FCF
24.17x
41.08x
80.44x
29.12x
FCF Yield
6.89%
3.98%
1.88%
5.2%
ende